Related Experiment Video
Updated: Sep 28, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children
Robert J Boyle1, Nigel Curtis, Nigel Kelly
1Department of Paediatrics, Murdoch Children's Research Institute, Melbourne University, Melbourne, Victoria, Australia. BobBoyle@doctors.org.uk.
Background:
Organisms of the spp., indole-positive spp., spp. and (ESCaPPM) group are a common cause of hospital-acquired bacteremia and share the potential to develop beta-lactam resistance during therapy. The emergence of such resistance may have adverse consequences, but the frequency with which this occurs has not been studied in children. It has been suggested that such organisms should be treated with combination antimicrobials or carbapenems, but the optimal regimen is uncertain. AIM To determine the frequency with which beta-lactam resistance develops during ESCaPPM sepsis in children and the optimal treatment of such sepsis.
Methods:
A review of the case notes and microbiologic records of all cases of ESCaPPM bacteremia and meningitis managed at a tertiary children's hospital during a 6-year period.
Results:
Fifty-eight cases were identified, and in three (5%) cases beta-lactam resistance emerged during treatment, with adverse clinical consequences in two cases. Clinical and microbiologic outcome was similar in those treated with carbapenems and in those treated with a beta-lactam and aminoglycoside combination. Cefotaxime resistance was found in 57, 30, 24 and 7% of children who had received carbapenems, cephalosporins, penicillins or no/other antimicrobials in the month before ESCaPPM sepsis, respectively.
Conclusions:
The emergence of beta-lactam resistance during treatment of ESCaPPM sepsis is uncommon in our hospital but can have adverse consequences. Where isolates are reported as susceptible to both classes of drugs, an extended spectrum penicillin in combination with an aminoglycoside may be preferable first line treatment of ESCaPPM sepsis to a carbapenem or quinolone.
Insights
Beta-lactam resistance emergence during Extended Spectrum Cephalosporin producing Gram-negative Pathogens (ESCaPPM) sepsis in children is uncommon but can lead to adverse outcomes. Combination therapy with extended spectrum penicillin and aminoglycoside may be preferred over carbapenems or quinolones.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Hospital-Acquired Infections
Background:
- Extended Spectrum Cephalosporin producing Gram-negative Pathogens (ESCaPPM) are significant causes of hospital-acquired bacteremia and meningitis in children.
- These organisms possess the potential for developing beta-lactam resistance during antimicrobial therapy, a phenomenon with potentially adverse clinical consequences.
- The frequency of beta-lactam resistance development and optimal treatment strategies for ESCaPPM infections in pediatric populations remain understudied.
Purpose of the Study:
- To determine the incidence of beta-lactam resistance emergence during the treatment of ESCaPPM sepsis in children.
- To evaluate the optimal therapeutic regimens for pediatric ESCaPPM sepsis, comparing combination antimicrobial therapy and carbapenems.
Main Methods:
- A retrospective review of case notes and microbiological records was conducted.
- The study encompassed all cases of ESCaPPM bacteremia and meningitis managed at a tertiary children's hospital over a six-year period.
Main Results:
- Fifty-eight cases of ESCaPPM sepsis were identified. Beta-lactam resistance emerged in 5% (3 cases) of these patients, leading to adverse clinical outcomes in two instances.
- Treatment outcomes were comparable between patients receiving carbapenems and those treated with a combination of beta-lactam and aminoglycoside.
- Prior antimicrobial exposure influenced resistance patterns, with higher rates of cefotaxime resistance observed in children with recent carbapenem, cephalosporin, or penicillin use.
Conclusions:
- The emergence of beta-lactam resistance during ESCaPPM sepsis treatment is infrequent in this pediatric cohort but carries significant clinical risks.
- For susceptible isolates, an extended spectrum penicillin combined with an aminoglycoside may be a preferred first-line treatment for ESCaPPM sepsis compared to carbapenems or quinolones.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial Meningitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis
